ChiCTR1800014387
尚未开始
/
化药
利多卡因
2018-01-10
/
Musculoskeletal disease of the upper limb that require surgery under regional anesthesia
前瞻性隨機比較使用利多卡因(Lidocaine)和羅呱卡因(Ropivacaine)對肋鎖間的鎖骨下窩臂叢神經阻滯後阻滯動態的效果
前瞻性隨機比較使用利多卡因(Lidocaine)和羅呱卡因(Ropivacaine)對肋鎖間的鎖骨下窩臂叢神經阻滯後阻滯動態的效果
比較使用利多卡因(Lidocaine)和羅呱卡因(Ropivacaine)對肋鎖間的鎖骨下窩臂叢神經阻滯後阻滯動態的效果
随机平行对照
其它
Randomized
Double-blind
Department of Anaesthesia & Intensive Care, CUHK
/
86
/
1990-01-01
1990-01-01
/
Patients who are between 20 to 70 years of age, of American Society of Anesthesiologists (ASA) status I to III, and planned for arm, forearm and hand surgery under regional anesthesia in Prince of Wales Hospital.;
请登录查看Patients who refuse regional anesthesia or unwilling to participate in the study; ASA physical status more than III; Pregnant patients; Patients with neuromuscular disorder; Prior surgery in the medial infraclavicular area on the same side of operation; Patients who are coagulopathic or taking anticoagulants; Patients suffering from dysaesthesia or chronic neuropathic pain at the site of surgery; History of local anesthetics allergy; Skin infection over the site of the block.;
请登录查看Department of Anaesthesia & Intensive Care, CUHK
/
Department of Anaesthesia & Intensive Care, CUHK的其他临床试验
- 實時超聲波引導脊椎麻醉:評估使用橫向平面超聲波檢查的新技術
- 前瞻性隨機比較使用利多卡因(Lidocaine)和羅呱卡因(Ropivacaine)對肋鎖間的鎖骨下窩臂叢神經阻滯後阻滯動態的效果
- 在超聲波引導從肋鎖間的鎖骨下窩臂叢神經阻滯之單次和多次注射效果對比的隨機性對照研究
- 膕窩處坐骨神經分叉前和分叉下神經阻滯效果對比的前瞻隨機性研究
- 保雲療法在治療頸部肌筋膜疼痛成效之前瞻隨機性研究及改善由護士轉介的分流過程
- Ultrasound-guided Multi-level Thoracic Paravertebral Block at three levels (T1, T3, and T5) in Combination with a pectoral nerve block for surgical anaesthesia during major breast cancer surgery: A Prospective Feasibility study
- Chronic Pain After Major Breast Cancer Surgery. A Retrospective Analysis of Single-injection Versus Multiple-injection of Thoracic Paravertebral Block
- Analgesic Efficacy and Pharmacokinetic of Ropivacaine Continuous Wound Instillation Following Hepatic Resection
Department of Anaesthesia & Intensive Care的其他临床试验
- Effects of GABA with Butyrate, GABA/Butyrate-producing Synbiotics on Pain Relief in Fibromyalgia: A Phase II, Multi-Center, Double-Blinded, Randomized-Controlled Trial
- Please fill in the data management platform. Impact of intravenous iron therapy on outcomes and exercise performance in cardiac surgical patients
- 亞洲深切治療學膿毒症病率及治療學
- 感染和膿毒症基因組廣泛表達:先導研究
- Ultrasound Guided Thoracic Paravertebral Block for Breast Cancer Surgery. A Retrospective Review of Complications.
- 實時超聲波引導脊椎麻醉:評估使用橫向平面超聲波檢查的新技術
- 臂叢神經阻滯對同側上肢局部組織血氧飽和度的影響
- 高流量鼻插管(HFNC)與標準低流量鼻插管在深度監察麻醉下進行左心耳閉塞(LAAO)患者的有益效果
- 前瞻性隨機比較使用利多卡因(Lidocaine)和羅呱卡因(Ropivacaine)對肋鎖間的鎖骨下窩臂叢神經阻滯後阻滯動態的效果
- 膕窩處坐骨神經分叉前和分叉下神經阻滯效果對比的前瞻隨機性研究
- 在成年危重病人中使用延長輸注右美托咪定注射液的藥代動力學模型的外部驗證
- Single shot versus continuous saphenous nerve block for postoperative pain management after total knee replacement: a randomised, double-blind trial
- 保雲療法在治療頸部肌筋膜疼痛成效之前瞻隨機性研究及改善由護士轉介的分流過程
- 利用血栓彈力圖來引導輸注血液製品對心臟手術後的出血量及血液製品使用量之影響
- 奧司他韋(「特敏福」)在患上嚴重流行性感冒病人的藥效學及藥力學
- 前瞻性隨機比較傳統體表定位胸椎旁麻醉及超聲波引導胸椎旁麻醉的血流動力學差異
- Closed-loop feedback computer-controlled phenylephrine for maintenance of blood pressure during spinal anaesthesia for caesarean section: randomized comparison of automated bolus versus infusion
- Efficacy of TTS-fentanyl given after weak opioid in patients with cancer related pain without stabilization phase: An open label study
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
利多卡因相关推荐
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

